Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Avacta Group (AVCT) Share Price

Price 83.50p on 19-05-2026 at 17:25:07
Change -2.50p -2.96%
Buy 85.00p
Sell 82.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Unknown 97,600.00 at 82.00p
Day's Volume: 3,178,805
Last Close: 82.00p
Open: 80.00p
ISIN: GB00BYYW9G87
Day's Range 80.00p - 84.00p
52wk Range: 27.25p - 90.50p
Market Capitalisation: £371.88m
VWAP: 83.27228p
Shares in Issue: 453.51m

Sector: Medicine and Biotech

Listed In: FTSE AIM All-Share,

Avacta Group (AVCT) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 97,600 82.00p OTC Trade
 17:06:45 - 19-May-26
Buy* 100,000 84.15p Ordinary
 16:42:45 - 19-May-26
Sell* 9 82.00p Uncrossing Trade
 16:35:14 - 19-May-26
Buy* 120 84.00p SI Trade
 16:27:52 - 19-May-26
Buy* 6,208 82.90p Ordinary
 16:27:46 - 19-May-26
Buy* 39,000 83.1945p Suspected BUY Trade
 16:24:59 - 19-May-26
Buy* 9,990 82.70p Ordinary
 16:23:44 - 19-May-26
Buy* 15,010 82.725p Ordinary
 16:21:40 - 19-May-26
Sell* 40,000 82.26p Ordinary
 16:16:28 - 19-May-26
Buy* 728 82.80p Ordinary
 16:16:10 - 19-May-26
See more Avacta Group trades

Avacta Group (AVCT) Share Price History

Time period:
to
Date Open High Low Close Volume
18th May 2026 (Mon) 86.50 85.50 84.00 84.50 1,505,495
15th May 2026 (Fri) 87.50 87.50 86.00 86.50 1,225,501
14th May 2026 (Thu) 89.00 88.00 86.90 86.90 1,283,028
13th May 2026 (Wed) 84.00 89.50 84.00 89.00 1,373,454
12th May 2026 (Tue) 90.00 90.00 83.50 85.50 3,450,117
11th May 2026 (Mon) 82.50 90.50 88.00 88.00 6,026,785
8th May 2026 (Fri) 82.00 83.00 78.00 82.50 5,285,692
7th May 2026 (Thu) 71.00 82.50 81.00 81.00 6,910,424
6th May 2026 (Wed) 78.00 76.40 71.00 71.00 2,377,307
5th May 2026 (Tue) 74.00 77.50 74.50 77.00 3,007,077
4th May 2026 (Mon) 75.00 75.00 75.00 75.00 0
1st May 2026 (Fri) 73.00 75.00 72.50 75.00 1,637,187
30th Apr 2026 (Thu) 72.00 74.00 74.00 74.00 1,211,042
29th Apr 2026 (Wed) 74.00 74.00 72.00 72.00 1,789,555
28th Apr 2026 (Tue) 75.50 74.00 73.60 73.60 1,158,888
27th Apr 2026 (Mon) 75.50 76.00 74.50 75.50 1,667,214
24th Apr 2026 (Fri) 76.00 76.50 74.30 74.30 1,813,647
23rd Apr 2026 (Thu) 76.50 76.50 74.00 76.50 1,940,829
22nd Apr 2026 (Wed) 80.50 78.50 75.00 75.00 2,251,358
21st Apr 2026 (Tue) 77.00 81.00 77.00 79.60 3,231,700
20th Apr 2026 (Mon) 77.00 78.00 76.50 77.00 1,956,408
See more Avacta Group price history

Avacta Group (AVCT) Regulatory News

Date Source Headline
13th May 2026 7:00 am RNS Notice of Preliminary Results and Presentation
13th May 2026 7:00 am RNS Issue of Equity and Total Voting Rights
6th May 2026 7:00 am RNS Pre|CISION® payload release vs approved ADCs
28th Apr 2026 7:00 am RNS Block Listing Six Monthly Return
21st Apr 2026 7:00 am RNS Avacta data AACR underline AVA6103 profile
14th Apr 2026 11:37 am RNS-R Christina Coughlin - In Vivo 2026 Rising Leader
9th Apr 2026 7:00 am RNS Q1 2026 Business Update
8th Apr 2026 7:00 am RNS-R Avacta Announces Science Day 2026
31st Mar 2026 7:00 am RNS First patient treated in Phase 1 trial of AVA6103
27th Mar 2026 7:00 am RNS Result of Oversubscribed Fundraise
See more Avacta Group regulatory news

Avacta Group (AVCT) Share News

Avacta Group annual loss widens as cancer treatment trial results loom

19th May 2026 11:07

(Alliance News) - Avacta Group PLC on Tuesday said clinical data from two cancer trials is expected to be released this year as it reported a widened annual pretax loss. Read More

TRADING UPDATES: Vaalco says remainder of 2026 to be "very profitable"

21st Apr 2026 22:53

(Alliance News) - The following is a round-up of updates by London-listed companies, issued last Wednesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Somero Enterprises extends buyback to USD6.0 million

9th Apr 2026 20:07

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

Avacta hails "important milestones" in start of "transformative" year

9th Apr 2026 13:04

(Alliance News) - Avacta Group PLC on Thursday said it "continued to build momentum" in the first quarter, highlighting favourable developments for its oncology products. Read More

IN BRIEF: Avacta raises GBP10 million in equity for clinical tests

27th Mar 2026 09:22

Avacta Group PLC - London-based biopharmaceutical company developing a tumour-activated oncology delivery platform - Raises GBP10 million from a placing of and subscription to 15.9 million new shares at 63 pence each. The new shares represent 3.6% of Avacta's total prior to the issuance. Two non-executive directors, Richard Hughes and David Bryant, contribute a total of GBP550,000 to the raise. The share offer is run by Zeus Capital as broker and bookrunner. Zeus will receive warrants over 4.4 million new shares at the same 63p price, exercisable over five years. The raise is in line with the plan announced after the London market close on Thursday. The fresh cash will be used to progress Avacta's research and development programmes into early in the first quarter of 2027, providing enough cash to get to initial data from a phase 1a trial of AVA6103, its second clinical program. AVA6103, a peptide drug conjugate. Read More

See more Avacta Group news
FTSE 100 Latest
Value10,330.55
Change6.80

Login to your account

Forgot Password?

Not Registered